Literature DB >> 3625039

Contraceptive steroids increase cholesterol in bile: mechanisms of action.

F Kern, G T Everson.   

Abstract

Contraceptive steroids increase the risk of acquiring cholesterol gallstones. The factors responsible include an increase in cholesterol saturation of bile and an increase in rate of secretion of cholesterol into bile. The goal of this study was to investigate the mechanism(s) of these increases in biliary cholesterol. During the use of contraceptive steroids, cholesterol saturation of gallbladder bile and the amount of cholesterol secreted per mole of bile acid increased (P less than 0.05 and P less than 0.02, respectively). Cholesterol absorption, cholesterol synthesis, chylomicron remnant clearance, and the concentration of plasma and lipoprotein lipids were not altered by contraceptive steroids. Despite this apparent lack of effect, important correlations were present during steroid use. LDL (low density lipoprotein) cholesterol increased as dietary cholesterol increased (r = 0.58, P less than 0.025). Cholesterol synthesis correlated directly with VLDL cholesterol concentration (r = 0.64, P less than 0.01), biliary cholesterol secretion (r = 0.68, P less than 0.01) and with molar percent cholesterol in bile (r = 0.49, P = 0.06). Chylomicron remnant clearance also correlated with cholesterol secretion (r = 0.85, P less than 0.001). As either remnant uptake or synthesis increased, the effect of the other source of hepatic cholesterol on biliary cholesterol secretion diminished. These relationships were not observed in the same subjects when they were not taking the hormones. The findings suggest that both newly synthesized and dietary cholesterol contribute to the cholesterol secreted in bile. This is consistent with the hypothesis that cholesterol for secretion into bile and VLDL is derived from a common metabolic pool of free cholesterol. It is proposed that contraceptive steroids exert their effect on biliary cholesterol by increasing cholesterol entering the pool and/or by inhibiting hepatic ACAT (acylcoenzyme A:cholesterol acyltransferase) activity, a known effect of progesterone, so that an increase in free cholesterol entering the pool leads to an increase in output.

Entities:  

Keywords:  Biliary Tract Diseases; Biology; Contraception; Contraceptive Methods--side effects; Diseases; Examinations And Diagnoses; Family Planning; Gallbladder Diseases--etiology; Laboratory Examinations And Diagnoses; Lipid Metabolic Effects; Lipids; Measurement; Oral Contraceptives--side effects; Physiology; Research Methodology

Mesh:

Substances:

Year:  1987        PMID: 3625039

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  10 in total

Review 1.  Defective acid base regulation by the gall bladder epithelium and its significance for gall stone formation.

Authors:  J N Plevris; I A Bouchier
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

2.  Cigarette smoking and parity as risk factors for the development of symptomatic gall bladder disease in women: results of the Royal College of General Practitioners' oral contraception study.

Authors:  F E Murray; R F Logan; P C Hannaford; C R Kay
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

3.  Progesterone alters biliary flow dynamics.

Authors:  S Tierney; A Nakeeb; O Wong; P A Lipsett; S Sostre; H A Pitt; K D Lillemoe
Journal:  Ann Surg       Date:  1999-02       Impact factor: 12.969

4.  Alterations in gallbladder emptying and bile retention in the absence of changes in bile lithogenicity in postmenopausal women on hormone replacement therapy.

Authors:  Radha K Dhiman; Pralay K Sarkar; Arpita Sharma; Kala Vasishta; Krishan K Kohli; Sanjay Gupta; Sudha Suri; Yogesh Chawla
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

5.  Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism.

Authors:  G T Everson; C McKinley; F Kern
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

Review 6.  Drug-induced gallbladder disease. Incidence, aetiology and management.

Authors:  P P Michielsen; H Fierens; Y M Van Maercke
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

7.  The deletion of the estrogen receptor α gene reduces susceptibility to estrogen-induced cholesterol cholelithiasis in female mice.

Authors:  Ornella de Bari; Helen H Wang; Piero Portincasa; Min Liu; David Q-H Wang
Journal:  Biochim Biophys Acta       Date:  2015-07-30

Review 8.  New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation.

Authors:  Helen H Wang; Min Liu; Deborah J Clegg; Piero Portincasa; David Q-H Wang
Journal:  Biochim Biophys Acta       Date:  2009-07-06

9.  Effects of dietary cholesterol on cholesterol and bile acid homeostasis in patients with cholesterol gallstones.

Authors:  F Kern
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

10.  Inappropriate hepatic cholesterol synthesis expands the cellular pool of sterol available for recruitment by bile acids in the rat.

Authors:  L E Bilhartz; D K Spady; J M Dietschy
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.